FR2835254B1 - THIAZOLE DERIVATIVES IN THE TREATMENT OF NEUROLOGICAL DISEASES - Google Patents

THIAZOLE DERIVATIVES IN THE TREATMENT OF NEUROLOGICAL DISEASES

Info

Publication number
FR2835254B1
FR2835254B1 FR0200905A FR0200905A FR2835254B1 FR 2835254 B1 FR2835254 B1 FR 2835254B1 FR 0200905 A FR0200905 A FR 0200905A FR 0200905 A FR0200905 A FR 0200905A FR 2835254 B1 FR2835254 B1 FR 2835254B1
Authority
FR
France
Prior art keywords
treatment
neurological diseases
thiazole derivatives
thiazole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0200905A
Other languages
French (fr)
Other versions
FR2835254A1 (en
Inventor
Jeremiah Harnett
Christine Dolo
De Lassauniere Pierre Chabrier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority to FR0200905A priority Critical patent/FR2835254B1/en
Priority to ARP030100208A priority patent/AR038219A1/en
Priority to PCT/FR2003/000228 priority patent/WO2003062232A1/en
Publication of FR2835254A1 publication Critical patent/FR2835254A1/en
Application granted granted Critical
Publication of FR2835254B1 publication Critical patent/FR2835254B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR0200905A 2002-01-25 2002-01-25 THIAZOLE DERIVATIVES IN THE TREATMENT OF NEUROLOGICAL DISEASES Expired - Fee Related FR2835254B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0200905A FR2835254B1 (en) 2002-01-25 2002-01-25 THIAZOLE DERIVATIVES IN THE TREATMENT OF NEUROLOGICAL DISEASES
ARP030100208A AR038219A1 (en) 2002-01-25 2003-01-24 TIAZOL DERIVATIVES USED IN THE TREATMENT OF NEUROLOGICAL DISEASES
PCT/FR2003/000228 WO2003062232A1 (en) 2002-01-25 2003-01-24 Derivatives of thiazoles used for the treatment of neurological diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0200905A FR2835254B1 (en) 2002-01-25 2002-01-25 THIAZOLE DERIVATIVES IN THE TREATMENT OF NEUROLOGICAL DISEASES

Publications (2)

Publication Number Publication Date
FR2835254A1 FR2835254A1 (en) 2003-08-01
FR2835254B1 true FR2835254B1 (en) 2006-04-07

Family

ID=27589580

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0200905A Expired - Fee Related FR2835254B1 (en) 2002-01-25 2002-01-25 THIAZOLE DERIVATIVES IN THE TREATMENT OF NEUROLOGICAL DISEASES

Country Status (3)

Country Link
AR (1) AR038219A1 (en)
FR (1) FR2835254B1 (en)
WO (1) WO2003062232A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1470818B1 (en) * 2003-04-25 2006-07-26 Neuro3D Use of piperazine phenothiazine derivatives in the manufacture of a medicament with neuroprotector and/or neurotrophic effects on cns and/or pns
MX2008002061A (en) 2005-08-18 2008-04-16 Hoffmann La Roche Thiazolyl piperidine derivatives.
GB0614365D0 (en) * 2006-07-19 2006-08-30 Proaxon Ltd Pharmaceutical compositions and their use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4636516A (en) * 1981-02-19 1987-01-13 Yamanouchi Pharmaceutical Co., Ltd. 3,5-di-tert-butyl-4-hydroxyphenyl-substituted heterocyclic compounds
DK1130017T3 (en) * 1990-11-30 2005-10-10 Otsuka Pharma Co Ltd Azole derivatives and their use as superoxide radical inhibitors
CN1382140A (en) * 1999-07-09 2002-11-27 奥索-麦克尼尔药品公司 Neurotrophic pyrrolidines and piperidines and related compositions containing them
TWI283577B (en) * 1999-10-11 2007-07-11 Sod Conseils Rech Applic Pharmaceutical composition of imidazole derivatives acting as modulators of sodium channels and the use thereof

Also Published As

Publication number Publication date
FR2835254A1 (en) 2003-08-01
WO2003062232A1 (en) 2003-07-31
AR038219A1 (en) 2005-01-05

Similar Documents

Publication Publication Date Title
ATE344253T1 (en) THIAZOLE DERIVATIVES FOR THE TREATMENT OF PPAR-LATED DISEASES
CY2015025I2 (en) METHODS FOR THE TREATMENT OF PARKINSON'S DISEASE
HK1079998A1 (en) Use of epothilones in the treatment of brain diseases associated with proliferative processes
DE60325209D1 (en) DIARYLUTE DERIVATIVES SUITABLE FOR THE TREATMENT OF PROTEIN KINASE-DEPENDENT DISEASES
FR13C0060I2 (en) FLUORO-SUBSTITUTED OMEGA-CARBOXYARYLDIPHENYLUREA FOR THE TREATMENT AND PREVENTION OF DISEASES AND CONDITIONS
NO20031442D0 (en) Morpholine-acetamide derivatives for the treatment of inflammatory diseases
ATE440866T1 (en) NOGO-A-NEUTRALIZING IMMUNOLOBULINES FOR THE TREATMENT OF NEUROLOGICAL DISEASES
GB0312832D0 (en) 2-amino-pyridine derivatives useful for the treatment of diseases
NO20041882L (en) Methods for the treatment of ocular neovascular diseases.
ATE426816T1 (en) EARLY DIAGNOSIS OF CONFORMATIONAL DISEASES
IS7623A (en) Anticoagulant tablet formulation of pramipexole
FI20060154A (en) Treatment of neurogenerative conditions
NL1026327A1 (en) 2-Amino-pyridine derivatives useful for the treatment of diseases.
EP1487446A4 (en) Bicyclic heterocycles for the treatment of diabetes and other diseases
AU2003268531A8 (en) Materials and methods for treatment of allergic diseases
MA28806B1 (en) ARYLSULFONYLSTILBENE DERIVATIVES FOR THE TREATMENT OF INSOMNIA AND RELATED CONDITIONS
ATE413399T1 (en) MORPHOLINYL UREA DERIVATIVES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH INFLAMMATORY PROCESSES
PT1411926E (en) INTEGRINE INHIBITORS FOR THE TREATMENT OF OPHTHALMIC DISEASES
EP1487443A4 (en) Heterocyclic amide derivatives for the treatment of diabetes and other diseases
FR2883182B1 (en) VITAMIN COMPOSITION USEFUL IN THE TREATMENT OF OCULAR DISEASES
ID27576A (en) USE OF CYCOSPORINE IN TREATMENT OF AUTOIMUN DISEASE DISEASES
GB0321384D0 (en) Pteridine derivatives for the treatment of septic shock and TNF-alpha- related diseases
FR2835254B1 (en) THIAZOLE DERIVATIVES IN THE TREATMENT OF NEUROLOGICAL DISEASES
DE602004014138D1 (en) BENZOTHIAZOLE DERIVATIVES AND ITS APPLICATION IN THE TREATMENT OF ADENOSINE A2A RECEPTOR MEDIATED DISEASES
DE60311822D1 (en) NEW PIPERAZINYL-PYRAZINONE DERIVATIVES FOR THE TREATMENT OF 5-HT2A RECEPTOR-RELATED DISEASES

Legal Events

Date Code Title Description
CA Change of address
CD Change of name or company name
ST Notification of lapse

Effective date: 20100930